WHS General Session: From Omics to Outcomes

In this session, Dr. Aristidis Veves will explore how cutting-edge omics technologies are unlocking the cellular and molecular signatures of healing versus non-healing in diabetic foot ulcers. His work sheds light on specific cell populations that may determine outcomes in this challenging patient population. Building on that foundation, Dr. Rob Fraser will take us from insight to impact by showing how clinical innovations are being scaled into commercial platforms that drive improved outcomes in wound care. Together, the talks will illustrate the full pathway from molecular discovery through translational development and real-world adoption.

Omic Studies for the Diabetic Foot Ulceration Aristidis Veves, MD, DSc

Bridging the Gap: Scaling Innovation from Clinical Insight to Commercialization Rob Fraser, MN, RN, NSWOC, WOCC(C)